Biopharmaceutical Fermentation System Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the biopharmaceutical fermentation system market looks promising with opportunities in applications, such as recombinant proteins, monoclonal antibodies, antibiotics, and probiotics. The global biopharmaceutical fermentation system market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing the demand for biotech based drugs and rising research and development activities to produce novel biological drugs.
A total of XX figures / charts and XX tables are provided in this more than 150 page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global biopharmaceutical fermentation system market report, please download the report brochure.
In this market, downstream products is the largest product segment of biopharmaceutical fermentation system, whereas development of recombinant proteins is the largest application. Growth in various segments of the biopharmaceutical fermentation system market are given below:
The study includes trends and forecast for the global biopharmaceutical fermentation system market by product, application, end use, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Within this market, recombinant proteins will remain the largest application segment over the forecast period due to high reliance on microbial system for recombinant protein production, increased investment in research activities and the introduction of new protein, and development of recombinant therapeutic antibodies and proteins.
North America will remain the largest region over the forecast period due to well established healthcare infrastructure, presence of key players, and rising industrialization in the region.
Features of the Global Biopharmaceutical Fermentation System Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global biopharmaceutical fermentation system market by product (upstream products [fermenters, bioprocess analyzers, process monitoring devices, culture and media preparation, culture media, buffers and inducers, and other upstream products] and downstream products [filtration and separation systems, chromatography, consumables and accessories, and other downstream products]), application (recombinant proteins, monoclonal antibodies, antibiotics, and probiotics), end use (biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, and food industry), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global biopharmaceutical fermentation system market?
Q.5 What are the business risks and threats to the global biopharmaceutical fermentation system market?
Q.6 What are the emerging trends in this biopharmaceutical fermentation system market and the reasons behind them?
Q.7 What are some changing demands of customers in this biopharmaceutical fermentation system market?
Q.8 What are the new developments in this biopharmaceutical fermentation system market? Which companies are leading these developments?
Q.9 Who are the major players in this biopharmaceutical fermentation system market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this biopharmaceutical fermentation system market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global biopharmaceutical fermentation system market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Upstream Products
(Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)), Application (Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics), and End Use (Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingodm, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the biopharmaceutical fermentation system market looks promising with opportunities in applications, such as recombinant proteins, monoclonal antibodies, antibiotics, and probiotics. The global biopharmaceutical fermentation system market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing the demand for biotech based drugs and rising research and development activities to produce novel biological drugs.
A total of XX figures / charts and XX tables are provided in this more than 150 page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global biopharmaceutical fermentation system market report, please download the report brochure.
In this market, downstream products is the largest product segment of biopharmaceutical fermentation system, whereas development of recombinant proteins is the largest application. Growth in various segments of the biopharmaceutical fermentation system market are given below:
The study includes trends and forecast for the global biopharmaceutical fermentation system market by product, application, end use, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Upstream Products
- Fermenters
- Bioprocess Analyzers
- Process Monitoring Devices
- Culture and Media Preparation
- Culture Media
- Buffers and Inducers
- Other Upstream Products
- Downstream Products
- Filtration and Separation Systems
- Chromatography
- Consumables and Accessories
- Other Downstream Products
- Recombinant Proteins
- Monoclonal Antibodies
- Antibiotics
- Probiotics
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Contract Research Organizations
- Academic Research Institutes
- Food Industry
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Within this market, recombinant proteins will remain the largest application segment over the forecast period due to high reliance on microbial system for recombinant protein production, increased investment in research activities and the introduction of new protein, and development of recombinant therapeutic antibodies and proteins.
North America will remain the largest region over the forecast period due to well established healthcare infrastructure, presence of key players, and rising industrialization in the region.
Features of the Global Biopharmaceutical Fermentation System Market
- Market Size Estimates: Global biopharmaceutical fermentation system market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global biopharmaceutical fermentation system market size by various segments, such as product, application, end use in terms of value.
- Regional Analysis: Global biopharmaceutical fermentation system market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and region for the global biopharmaceutical fermentation system market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global biopharmaceutical fermentation system market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global biopharmaceutical fermentation system market by product (upstream products [fermenters, bioprocess analyzers, process monitoring devices, culture and media preparation, culture media, buffers and inducers, and other upstream products] and downstream products [filtration and separation systems, chromatography, consumables and accessories, and other downstream products]), application (recombinant proteins, monoclonal antibodies, antibiotics, and probiotics), end use (biopharmaceutical companies, contract manufacturing organizations, contract research organizations, academic research institutes, and food industry), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global biopharmaceutical fermentation system market?
Q.5 What are the business risks and threats to the global biopharmaceutical fermentation system market?
Q.6 What are the emerging trends in this biopharmaceutical fermentation system market and the reasons behind them?
Q.7 What are some changing demands of customers in this biopharmaceutical fermentation system market?
Q.8 What are the new developments in this biopharmaceutical fermentation system market? Which companies are leading these developments?
Q.9 Who are the major players in this biopharmaceutical fermentation system market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this biopharmaceutical fermentation system market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global biopharmaceutical fermentation system market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Upstream Products
(Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)), Application (Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics), and End Use (Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingodm, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biopharmaceutical Fermentation System Market Trends and Forecast
3.3: Global Biopharmaceutical Fermentation System Market by Product
3.3.1: Upstream Products
3.3.1.1: Fermenters
3.3.1.2: Bioprocess Analyzers
3.3.1.3: Process Monitoring Devices
3.3.1.4: Culture and Media Preparation
3.3.1.5: Culture Media
3.3.1.6: Buffers and Inducers
3.3.1.7: Other Upstream Products
3.3.2: Downstream Products
3.3.2.1: Filtration and Separation Systems
3.3.2.2: Chromatography
3.3.2.3: Consumables and Accessories
3.3.2.4: Other Downstream Products
3.4: Global Biopharmaceutical Fermentation System Market by Application
3.4.1: Recombinant Proteins
3.4.2: Monoclonal Antibodies
3.4.3: Antibiotics
3.4.4: Probiotics
3.5: Global Biopharmaceutical Fermentation System Market by End Use
3.5.1: Biopharmaceutical Companies
3.5.2: Contract Manufacturing Organizations
3.5.3: Contract Research Organizations
3.5.4: Academic Research Institutes
3.5.5: Food Industry
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Biopharmaceutical Fermentation System Market by Region
4.2: North American Biopharmaceutical Fermentation System Market
4.2.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.2.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.2.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.2.4: The United States Biopharmaceutical Fermentation System Market
4.2.5: The Canadian Biopharmaceutical Fermentation System Market
4.2.6: The Mexican Biopharmaceutical Fermentation System Market
4.3: European Biopharmaceutical Fermentation System Market
4.3.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.3.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.3.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.3.4: The United Kingdom Biopharmaceutical Fermentation System Market
4.3.5: The Spanish Biopharmaceutical Fermentation System Market
4.3.6: The German Biopharmaceutical Fermentation System Market
4.3.7: The French Biopharmaceutical Fermentation System Market
4.4: APAC Biopharmaceutical Fermentation System Market
4.4.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.4.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.4.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.4.4: The Chinese Biopharmaceutical Fermentation System Market
4.4.5: The Indian Biopharmaceutical Fermentation System Market
4.4.6: The Japanese Biopharmaceutical Fermentation System Market
4.5: ROW Biopharmaceutical Fermentation System Market
4.5.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.5.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.5.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.5.4: Brazilian Biopharmaceutical Fermentation System Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Product
7.1.2: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Application
7.1.3: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by End Use
7.1.4: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Region
7.2: Emerging Trends in the Global Biopharmaceutical Fermentation System Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biopharmaceutical Fermentation System Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceutical Fermentation System Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: GE Healthcare
8.2: Therm Fisher Scientific
8.3: Danaher Corporation
8.4: Sartorius StedimBiotech
8.5: Merck
8.6: Eppendorf
8.7: Roche
8.8: Nova Biomedicals
8.9: Lonza
8.10: Becton Dickinson and Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biopharmaceutical Fermentation System Market Trends and Forecast
3.3: Global Biopharmaceutical Fermentation System Market by Product
3.3.1: Upstream Products
3.3.1.1: Fermenters
3.3.1.2: Bioprocess Analyzers
3.3.1.3: Process Monitoring Devices
3.3.1.4: Culture and Media Preparation
3.3.1.5: Culture Media
3.3.1.6: Buffers and Inducers
3.3.1.7: Other Upstream Products
3.3.2: Downstream Products
3.3.2.1: Filtration and Separation Systems
3.3.2.2: Chromatography
3.3.2.3: Consumables and Accessories
3.3.2.4: Other Downstream Products
3.4: Global Biopharmaceutical Fermentation System Market by Application
3.4.1: Recombinant Proteins
3.4.2: Monoclonal Antibodies
3.4.3: Antibiotics
3.4.4: Probiotics
3.5: Global Biopharmaceutical Fermentation System Market by End Use
3.5.1: Biopharmaceutical Companies
3.5.2: Contract Manufacturing Organizations
3.5.3: Contract Research Organizations
3.5.4: Academic Research Institutes
3.5.5: Food Industry
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Biopharmaceutical Fermentation System Market by Region
4.2: North American Biopharmaceutical Fermentation System Market
4.2.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.2.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.2.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.2.4: The United States Biopharmaceutical Fermentation System Market
4.2.5: The Canadian Biopharmaceutical Fermentation System Market
4.2.6: The Mexican Biopharmaceutical Fermentation System Market
4.3: European Biopharmaceutical Fermentation System Market
4.3.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.3.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.3.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.3.4: The United Kingdom Biopharmaceutical Fermentation System Market
4.3.5: The Spanish Biopharmaceutical Fermentation System Market
4.3.6: The German Biopharmaceutical Fermentation System Market
4.3.7: The French Biopharmaceutical Fermentation System Market
4.4: APAC Biopharmaceutical Fermentation System Market
4.4.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.4.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.4.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.4.4: The Chinese Biopharmaceutical Fermentation System Market
4.4.5: The Indian Biopharmaceutical Fermentation System Market
4.4.6: The Japanese Biopharmaceutical Fermentation System Market
4.5: ROW Biopharmaceutical Fermentation System Market
4.5.1: Market by Product: Upstream Products (Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, and Other Upstream Products) and Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, and Other Downstream Products)
4.5.2: Market by Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, and Probiotics
4.5.3: Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, and Food Industry
4.5.4: Brazilian Biopharmaceutical Fermentation System Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Product
7.1.2: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Application
7.1.3: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by End Use
7.1.4: Growth Opportunities for the Global Biopharmaceutical Fermentation System Market by Region
7.2: Emerging Trends in the Global Biopharmaceutical Fermentation System Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biopharmaceutical Fermentation System Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopharmaceutical Fermentation System Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: GE Healthcare
8.2: Therm Fisher Scientific
8.3: Danaher Corporation
8.4: Sartorius StedimBiotech
8.5: Merck
8.6: Eppendorf
8.7: Roche
8.8: Nova Biomedicals
8.9: Lonza
8.10: Becton Dickinson and Company
